JP2024508498A5 - - Google Patents
Info
- Publication number
- JP2024508498A5 JP2024508498A5 JP2023552525A JP2023552525A JP2024508498A5 JP 2024508498 A5 JP2024508498 A5 JP 2024508498A5 JP 2023552525 A JP2023552525 A JP 2023552525A JP 2023552525 A JP2023552525 A JP 2023552525A JP 2024508498 A5 JP2024508498 A5 JP 2024508498A5
- Authority
- JP
- Japan
- Prior art keywords
- reboxetine
- acceptable salt
- oxybutynin
- pharmacologically acceptable
- mra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156463P | 2021-03-04 | 2021-03-04 | |
| US63/156,463 | 2021-03-04 | ||
| PCT/US2022/018604 WO2022187420A1 (en) | 2021-03-04 | 2022-03-03 | Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508498A JP2024508498A (ja) | 2024-02-27 |
| JP2024508498A5 true JP2024508498A5 (cg-RX-API-DMAC7.html) | 2025-03-10 |
Family
ID=80999274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552525A Pending JP2024508498A (ja) | 2021-03-04 | 2022-03-03 | 睡眠時無呼吸の治療における使用のためのレボキセチン及びムスカリン受容体拮抗薬(mra)の組み合わせ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240139200A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4301353A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508498A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230154186A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116916909A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022231133A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3210092A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022187420A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| MXPA03006003A (es) * | 2001-01-02 | 2005-09-08 | Upjohn Co | Nuevas combinaciones de farmacos. |
| MY136318A (en) * | 2002-07-25 | 2008-09-30 | Pharmacia Corp | Sustained-release tablet composition |
| CN119185558A (zh) * | 2017-04-28 | 2024-12-27 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
| CN111670050A (zh) * | 2018-01-30 | 2020-09-15 | 爱普宁公司(特拉华) | 用于治疗睡眠呼吸暂停的方法和组合物 |
-
2022
- 2022-03-03 CA CA3210092A patent/CA3210092A1/en active Pending
- 2022-03-03 WO PCT/US2022/018604 patent/WO2022187420A1/en not_active Ceased
- 2022-03-03 AU AU2022231133A patent/AU2022231133A1/en not_active Abandoned
- 2022-03-03 US US18/548,604 patent/US20240139200A1/en active Pending
- 2022-03-03 CN CN202280018649.9A patent/CN116916909A/zh active Pending
- 2022-03-03 KR KR1020237029510A patent/KR20230154186A/ko active Pending
- 2022-03-03 JP JP2023552525A patent/JP2024508498A/ja active Pending
- 2022-03-03 EP EP22714033.2A patent/EP4301353A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7488201B2 (ja) | デクスメデトミジンを含むフィルム製剤、及びその作製方法 | |
| JP2020517719A5 (cg-RX-API-DMAC7.html) | ||
| CN103596551B (zh) | 含有用于掩味的离子交换树脂的食用口服条或糯米纸囊剂型 | |
| US20110280925A1 (en) | Dual And Single Layer Dosage Forms | |
| CN110799181A (zh) | 用于治疗睡眠呼吸暂停的方法和组合物 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| TW200932207A (en) | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas | |
| RU2007104095A (ru) | Применение твердой пероральной дозировочной композиции пролонгированного действия для приготовления лекарственных средств | |
| US20110160264A1 (en) | Orally administrable film dosage forms containing ondansetron | |
| TW201834654A (zh) | 包含task-1與task-3通道抑制劑之醫藥劑型及其用於呼吸病症治療之用途 | |
| JP5362151B2 (ja) | Pgd2拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬 | |
| TWI820673B (zh) | 布瑞哌唑口溶膜組合物、其製備方法及用途 | |
| AU2008259864C1 (en) | Methods and compositions for administration of Oxybutynin | |
| CN120617220A (zh) | 一种地氯雷他定口溶膜组合物、其制备方法及应用 | |
| TWI820674B (zh) | 布瑞哌唑物口腔薄膜劑、其製備方法及用途 | |
| TW200534852A (en) | 4-methylpyrazole formulations for inhibiting ethanol intolerance | |
| JP2024523876A5 (cg-RX-API-DMAC7.html) | ||
| JP2024511091A5 (cg-RX-API-DMAC7.html) | ||
| WO2008052431A1 (en) | Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder | |
| JP2024534173A5 (cg-RX-API-DMAC7.html) | ||
| CN108261411A (zh) | 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法 | |
| TW200533361A (en) | Medicinal composition for treating allergic symptoms | |
| CN117338717B (zh) | 一种黄芩素外用制剂及其在特应性皮炎治疗中的应用 | |
| JP5463019B2 (ja) | エピナスチン類とエフェドリン類とを含有する気道杯細胞過形成を抑制するための医薬組成物 | |
| JP2022538170A5 (cg-RX-API-DMAC7.html) |